Telephone
64.9.869.3035
Address
64 Richard Pearse Drive Mangere, Auckland 2022
Description
Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.44 - 0.87
Trade Value (12mth)
US$48,587.00
1 week
-3.67%
1 month
-11.02%
YTD
-36.36%
1 year
-36.75%
All time high
1.75
EPS 3 yr Growth
-51.70%
EBITDA Margin
-4.50%
Operating Cashflow
-$7m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
-2.20
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
343m
HALO Sector
Healthcare
Next Company Report Date
20-May-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
NZD
Short Sell (% of issue)
0.17
Date | Announcements |
---|---|
27 August 24 |
Change in substantial holding
×
Change in substantial holding |
26 August 24 |
Change in substantial holding
×
Change in substantial holding |
23 August 24 |
Notification regarding unquoted securities - ARX
×
Notification regarding unquoted securities - ARX |
23 August 24 |
Application for quotation of securities - ARX
×
Application for quotation of securities - ARX |
23 August 24 |
Application for quotation of securities - ARX
×
Application for quotation of securities - ARX |
23 August 24 |
Section 708A Notice
×
Section 708A Notice |
23 August 24 |
Notification of cessation of securities - ARX
×
Notification of cessation of securities - ARX |
23 August 24 |
Change of Director's Interest Notice - BW
×
Change of Director's Interest Notice - BW |
23 August 24 |
Change of Director's Interest Notice - DH
×
Change of Director's Interest Notice - DH |
24 July 24 |
June 2024 Quarterly Report and Appendix 4C
×
June 2024 Quarterly Report and Appendix 4C |
24 July 24 |
Investor Presentation
×
Investor Presentation |
23 July 24 |
Chairman's Address - AGM
×
Chairman's Address - AGM |
23 July 24 |
CEO Presentation - AGM
×
CEO Presentation - AGM |
23 July 24 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
17 July 24 |
Notification of Quarterly Results Webinar
×
Notification of Quarterly Results Webinar |
08 July 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
08 July 24 |
Proposed issue of securities - ARX
×
Proposed issue of securities - ARX |
08 July 24 |
Proposed issue of securities - ARX
×
Proposed issue of securities - ARX |
08 July 24 |
Notification of cessation of securities - ARX
×
Notification of cessation of securities - ARX |
24 June 24 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
24 June 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
24 May 24 |
Notice of AGM Date and Director Nomination Closing Date
×
Notice of AGM Date and Director Nomination Closing Date |
21 May 24 |
FY24 Appendix 4E and Full Year Results
×
FY24 Appendix 4E and Full Year Results |
21 May 24 |
FY24 Full Year Results Presentation
×
FY24 Full Year Results Presentation |
14 May 24 |
Notification of Full Year Results Webinar
×
Notification of Full Year Results Webinar |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.